Penserra Capital Management LLC Edwards Lifesciences Corp Transaction History

Penserra Capital Management LLC

$5.47 Billion
Q4 2024

A detailed history of Penserra Capital Management LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Penserra Capital Management LLC holds 1,546 shares of EW stock, worth $108,745. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,546

Previous 51 2931.37%

Holding current value

$108,745

Previous $3,000 3666.67%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$64.54 - $75.92 $96,487 - $113,500	1,495 Added 2931.37%	1,546 $113,000
Q3 2024 Nov 12, 2024	BUY	$59.7 - $93.78 $179 - $281	3 Added 6.25%	51 $3,000
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $199,992 - $263,458	-2,757 Reduced 98.29%	48 $4,000
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $37,087 - $46,733	-601 Reduced 17.65%	2,805 $213,000
Q3 2023 Nov 15, 2023	SELL	$69.28 - $93.38 $36,233 - $48,837	-523 Reduced 13.31%	3,406 $235,000
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $317,091 - $367,415	3,895 Added 11455.88%	3,929 $370,000
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $2,322 - $2,972	34 New	34 $2,000
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $69,682 - $88,675	-972 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $65,308 - $84,991	972 New	972 $77,000
Q2 2020 Aug 14, 2020	SELL	$57.54 - $76.95 $1.57 Million - $2.1 Million	-27,268 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $1.43 Million - $2.21 Million	27,268 New	27,268 $5.14 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $3.55 Million - $4.06 Million	-49,463 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$61.55 - $75.43 $3.04 Million - $3.73 Million	49,463 New	49,463 $10.9 Million
Q1 2019 May 08, 2019	SELL	$47.89 - $64.05 $2.31 Million - $3.09 Million	-48,292 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$46.41 - $56.94 $2.1 Million - $2.58 Million	45,348 Added 1540.35%	48,292 $7.4 Million
Q3 2018 Nov 05, 2018	BUY	$45.7 - $58.03 $19,011 - $24,140	416 Added 16.46%	2,944 $512,000
Q2 2018 Aug 13, 2018	SELL	$42.45 - $51.3 $541,874 - $654,844	-12,765 Reduced 83.47%	2,528 $368,000
Q1 2018 May 08, 2018	BUY	$37.19 - $47.45 $485,441 - $619,364	13,053 Added 582.72%	15,293 $2.13 Million
Q4 2017 Feb 07, 2018	BUY	$33.79 - $39.39 $11,894 - $13,865	352 Added 18.64%	2,240 $252,000
Q3 2017 Oct 26, 2017	BUY	$36.29 - $38.83 $8,128 - $8,697	224 Added 13.46%	1,888 $207,000
Q2 2017 Aug 21, 2017	BUY	N/A	1,664	1,664 $196,000

Others Institutions Holding EW

# of Institutions

1,383

Shares Held

487M

Call Options Held

6.71M

Put Options Held

3.17M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Account

Penserra Capital Management LLC Edwards Lifesciences Corp Transaction History